カテゴリ： P&S Market Research, 世界, 医療/バイオ

生体電気医療の世界市場：産業分析・成長予測（～2030）

■ 英語タイトル：Bioelectric Medicine Market Share Analysis by End User (Hospitals, Clinics, Ambulatory Surgery Centers), Application (Arrhythmia, Pain Management, Parkinson’s Disease, Depression, Ischemia, Epilepsy), Device Type (Implantable, Non-Invasive), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Spinal Cord Stimulators, Cochlear Implants, Deep-Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants) - Global Industry Growth and Demand Forecast to 2030

調査会社P&S Market Research社が発行したリサーチレポート（データ管理コード：PS23SEP044）

■ 発行会社/調査会社：P&S Market Research
■ 商品コード：PS23SEP044
■ 発行日：2023年2月
最新版(2025年又は2026年)はお問い合わせください。
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：240
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）

■ 販売価格オプション（消費税別）

Single User		見積依頼/購入/質問フォーム
5 User		見積依頼/購入/質問フォーム
Enterprise User		見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※P&S Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[生体電気医療の世界市場：産業分析・成長予測（～2030）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

P&S Intelligence社の最新レポートによると、2022年の生体電気医療市場規模は215億3,210万ドルで、今後5.2%のペースで拡大し、2030年には323億4,580万ドルに達する見込みです。
最も使用されている植込み型除細動器
- 植込み型除細動器は、幅広い用途に使用できるため、すべての製品の中で最も使用されています。その電気刺激能力により、心房細動、心室頻拍、心房粗動の治療に必要です。
- さらに、薬物療法や手術など、他の治療法とも併用されます。
- 高齢者層における心停止や神経疾患の増加が、このカテゴリーの成長を後押ししています。
- このような社会では、除細動器、脳深部刺激装置、心臓ペースメーカー、脊髄刺激装置などの植え込み型装置に対する需要が高まっています。

不整脈患者で最も高い生体電気医療ニーズ
不整脈カテゴリーは売上の約60%を占め、業界を支配しています。これは、植え込み型除細動器や心臓ペースメーカーが広く使用されている不整脈患者が増加しているためです。さらに、いくつかのプレーヤーは、共同研究、合併、パートナーシップを通じて、ビジネスの見通しを増やすことに重点を置いています。

生体電気医療の需要は北米で最も高い
北米は、研究開発投資の高さ、技術的に進歩したデバイスの受容の高まり、大手プレイヤーの存在、大規模な病院数により、過去に40%以上の最大の収益シェアを占めていました。さらに、医療費の増加がこの地域の業界を牽引する重要な要因となっています。さらに、アルツハイマー病、てんかん、脊髄損傷、不整脈など、多くの健康疾患の有病率が増加していること、医療インフラに対する政府支出が増加していること、臨床ラボや新しい診断技術に広くアクセスできることから、APACが最も急成長する見込みです。

植え込み型電気治療機器の受け入れ拡大
植え込み型電気治療器カテゴリーは、過去に約80％の最大シェアを占めていました。これは主に、多くの心血管疾患や神経疾患の有病率が増加していることと、製品の承認数が増加していることによるものです。

エンドユーザーとして最も急成長する病院
病院は、今後数年間で、7％前後の急成長を遂げるでしょう。これは、神経疾患や聴覚疾患の検出と治療のための最先端機器が利用可能であることと、これらの施設に熟練した医療従事者がいるためです。例えば、アルツハイマー病、不整脈、てんかん、慢性疼痛、網膜色素変性症などのいくつかの慢性疾患は、患者の入院につながります。2022年、アルツハイマー病協会によると、65歳以上のアメリカ人は約650万人、75歳以上のアメリカ人の約73%がアルツハイマー病を患っています。

第1章．調査範囲
第2章．調査方法
第3章．エグゼクティブサマリー
第4章．産業専門家の意見/KOL
第5章．市場指標
第6章．産業動向
第7章．世界市場
第8章．北米市場
第9章．ヨーロッパ市場
第10章．アジア太平洋市場
第11章．中南米市場
第12章．中東・アフリカ市場
第13章．アメリカ市場
第14章．カナダ市場
第15章．ドイツ市場
第16章．フランス市場
第17章．イギリス市場
第18章．イタリア市場
第19章．スペイン市場
第20章．日本市場
第21章．中国市場
第22章．インド市場
第23章．オーストラリア市場
第24章．韓国市場
第25章．ブラジル市場
第26章．メキシコ市場
第27章．サウジアラビア市場
第28章．南アフリカ市場
第29章．中東市場
第30章．競争状況
第31章．企業情報
第32章．付録

*** レポート目次（コンテンツ）***

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segment

1.4.1. Market size breakdown, by end user

1.4.2. Market size breakdown, by application

1.4.3. Market size breakdown, by device type

1.4.4. Market size breakdown, by product

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by End User (2017–2030)

7.3. Market Revenue, by Application (2017–2030)

7.4. Market Revenue, by Device Type (2017–2030)

7.5. Market Revenue, by Product (2017–2030)

7.6. Market Revenue, by Region (2017–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by End User (2017–2030)

8.3. Market Revenue, by Application (2017–2030)

8.4. Market Revenue, by Device Type (2017–2030)

8.5. Market Revenue, by Product (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by End User (2017–2030)

9.3. Market Revenue, by Application (2017–2030)

9.4. Market Revenue, by Device Type (2017–2030)

9.5. Market Revenue, by Product (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by End User (2017–2030)

10.3. Market Revenue, by Application (2017–2030)

10.4. Market Revenue, by Device Type (2017–2030)

10.5. Market Revenue, by Product (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by End User (2017–2030)

11.3. Market Revenue, by Application (2017–2030)

11.4. Market Revenue, by Device Type (2017–2030)

11.5. Market Revenue, by Product (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by End User (2017–2030)

12.3. Market Revenue, by Application (2017–2030)

12.4. Market Revenue, by Device Type (2017–2030)

12.5. Market Revenue, by Product (2017–2030)

12.6. Market Revenue, by Country (2017–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by End User (2017–2030)

13.3. Market Revenue, by Application (2017–2030)

13.4. Market Revenue, by Device Type (2017–2030)

13.5. Market Revenue, by Product (2017–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by End User (2017–2030)

14.3. Market Revenue, by Application (2017–2030)

14.4. Market Revenue, by Device Type (2017–2030)

14.5. Market Revenue, by Product (2017–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by End User (2017–2030)

15.3. Market Revenue, by Application (2017–2030)

15.4. Market Revenue, by Device Type (2017–2030)

15.5. Market Revenue, by Product (2017–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by End User (2017–2030)

16.3. Market Revenue, by Application (2017–2030)

16.4. Market Revenue, by Device Type (2017–2030)

16.5. Market Revenue, by Product (2017–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by End User (2017–2030)

17.3. Market Revenue, by Application (2017–2030)

17.4. Market Revenue, by Device Type (2017–2030)

17.5. Market Revenue, by Product (2017–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by End User (2017–2030)

18.3. Market Revenue, by Application (2017–2030)

18.4. Market Revenue, by Device Type (2017–2030)

18.5. Market Revenue, by Product (2017–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by End User (2017–2030)

19.3. Market Revenue, by Application (2017–2030)

19.4. Market Revenue, by Device Type (2017–2030)

19.5. Market Revenue, by Product (2017–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by End User (2017–2030)

20.3. Market Revenue, by Application (2017–2030)

20.4. Market Revenue, by Device Type (2017–2030)

20.5. Market Revenue, by Product (2017–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by End User (2017–2030)

21.3. Market Revenue, by Application (2017–2030)

21.4. Market Revenue, by Device Type (2017–2030)

21.5. Market Revenue, by Product (2017–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by End User (2017–2030)

22.3. Market Revenue, by Application (2017–2030)

22.4. Market Revenue, by Device Type (2017–2030)

22.5. Market Revenue, by Product (2017–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by End User (2017–2030)

23.3. Market Revenue, by Application (2017–2030)

23.4. Market Revenue, by Device Type (2017–2030)

23.5. Market Revenue, by Product (2017–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by End User (2017–2030)

24.3. Market Revenue, by Application (2017–2030)

24.4. Market Revenue, by Device Type (2017–2030)

24.5. Market Revenue, by Product (2017–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by End User (2017–2030)

25.3. Market Revenue, by Application (2017–2030)

25.4. Market Revenue, by Device Type (2017–2030)

25.5. Market Revenue, by Product (2017–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by End User (2017–2030)

26.3. Market Revenue, by Application (2017–2030)

26.4. Market Revenue, by Device Type (2017–2030)

26.5. Market Revenue, by Product (2017–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by End User (2017–2030)

27.3. Market Revenue, by Application (2017–2030)

27.4. Market Revenue, by Device Type (2017–2030)

27.5. Market Revenue, by Product (2017–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by End User (2017–2030)

28.3. Market Revenue, by Application (2017–2030)

28.4. Market Revenue, by Device Type (2017–2030)

28.5. Market Revenue, by Product (2017–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by End User (2017–2030)

29.3. Market Revenue, by Application (2017–2030)

29.4. Market Revenue, by Device Type (2017–2030)

29.5. Market Revenue, by Product (2017–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and Their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. Medtronic plc

31.1.1. Business overview

31.1.2. Product and service offerings

31.1.3. Key financial summary

31.2. Abbott Laboratories

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Boston Scientific Corporation

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. LivaNova PLC

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. Cochlear Limited

31.5.1. Business overview

31.5.2. Product and service offerings

31.5.3. Key financial summary

31.6. Nevro Corp.

31.6.1. Business overview

31.6.2. Product and service offerings

31.6.3. Key financial summary

31.7. Axonics Inc.

31.7.1. Business overview

31.7.2. Product and service offerings

31.7.3. Key financial summary

31.8. Second Sight Medical Products Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.8.3. Key financial summary

31.9. electroCore Inc.

31.9.1. Business overview

31.9.2. Product and service offerings

31.9.3. Key financial summary

31.10. Sonova Holding AG

31.10.1. Business overview

31.10.2. Product and service offerings

31.10.3. Key financial summary

31.11. Biowave Limited

31.11.1. Business overview

31.11.2. Product and service offerings

31.12. MicroPort Scientific Corporation

31.12.1. Business overview

31.12.2. Product and service offerings

31.12.3. Key financial summary

31.13. SetPoint Medical Corporation

31.13.1. Business overview

31.13.2. Product and service offerings

31.14. Sky Medical Technology

31.14.1. Business overview

31.14.2. Product and service offerings

31.15. Neuronetics Inc.

31.15.1. Business overview

31.15.2. Product and service offerings

31.15.3. Key financial summary

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF FIGURES

FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT

FIG 2 RESEARCH METHODOLOGY

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION

FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE

FIG 6 DATA TRIANGULATION APPROACH

FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)

FIG 8 GLOBAL BIOELECTRIC MEDICINE MARKET SUMMARY

FIG 9 BARGAINING POWER OF BUYERS

FIG 10 BARGAINING POWER OF SUPPLIERS

FIG 11 THREAT OF NEW ENTRANTS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF SUBSTITUTES

FIG 14 GLOBAL BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 15 GLOBAL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 16 GLOBAL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 17 GLOBAL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 18 GLOBAL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 19 MAJOR WORLDWIDE MARKETS FOR BIOELECTRIC MEDICINE, $M

FIG 20 NORTH AMERICA BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 21 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 22 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 23 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 24 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 25 NORTH AMERICA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 26 EUROPE BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 27 EUROPE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 28 EUROPE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 29 EUROPE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 30 EUROPE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 31 EUROPE BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 32 APAC BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 33 APAC BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 34 APAC BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 35 APAC BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 36 APAC BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 37 APAC BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 38 LATAM BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 39 LATAM BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 40 LATAM BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 41 LATAM BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 42 LATAM BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 43 LATAM BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 44 MEA BIOELECTRIC MEDICINE MARKET SNAPSHOT

FIG 45 MEA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 46 MEA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 47 MEA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 48 MEA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 49 MEA BIOELECTRIC MEDICINE MARKET, BY COUNTRY, $M (2017–2030)

FIG 50 U.S. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 51 U.S. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 52 U.S. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 53 U.S. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 54 CANADA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 55 CANADA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 56 CANADA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 57 CANADA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 58 GERMANY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 59 GERMANY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 60 GERMANY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 61 GERMANY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 62 FRANCE BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 63 FRANCE BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 64 FRANCE BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 65 FRANCE BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 66 U.K. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 67 U.K. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 68 U.K. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 69 U.K. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 70 ITALY BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 71 ITALY BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 72 ITALY BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 73 ITALY BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 74 SPAIN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 75 SPAIN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 76 SPAIN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 77 SPAIN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 78 JAPAN BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 79 JAPAN BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 80 JAPAN BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 81 JAPAN BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 82 CHINA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 83 CHINA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 84 CHINA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 85 CHINA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 86 INDIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 87 INDIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 88 INDIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 89 INDIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 90 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 91 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 92 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 93 AUSTRALIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 94 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 95 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 96 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 97 SOUTH KOREA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 98 BRAZIL BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 99 BRAZIL BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 100 BRAZIL BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 101 BRAZIL BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 102 MEXICO BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 103 MEXICO BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 104 MEXICO BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 105 MEXICO BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 106 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 107 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 108 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 109 SAUDI ARABIA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 110 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 111 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 112 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 113 SOUTH AFRICA BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 114 U.A.E. BIOELECTRIC MEDICINE MARKET, BY END USER, $M (2017–2030)

FIG 115 U.A.E. BIOELECTRIC MEDICINE MARKET, BY APPLICATION, $M (2017–2030)

FIG 116 U.A.E. BIOELECTRIC MEDICINE MARKET, BY DEVICE TYPE, $M (2017–2030)

FIG 117 U.A.E. BIOELECTRIC MEDICINE MARKET, BY PRODUCT, $M (2017–2030)

FIG 118 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 119 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 120 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 121 LIVANOVA PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 122 COCHLEAR LIMITED – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 123 NEVRO CORP. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 124 AXONICS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 125 SECOND SIGHT MEDICAL PRODUCTS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 126 ELECTROCORE INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 127 SONOVA HOLDING AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 128 MICROPORT SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

FIG 129 NEURONETICS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)

※参考情報

生体電気医療とは、体内で生じる電気的な信号や生体電気を利用して、医療のさまざまな分野で治療や診断を行う技術のことを指します。この医療分野は、神経、筋肉、心臓を含む生体の様々な機能において、電気的な信号が重要な役割を果たしていることに基づいています。電気的な信号は、生体の情報伝達や機能調整に必要不可欠であり、この特性を活用することで多くの病気や障害の治療方法が開発されています。

生体電気医療にはいくつかの種類があります。まず、神経刺激療法が挙げられます。これは、神経に電気刺激を加えることで、機能を回復させる治療法です。特に慢性痛や脊髄損傷に対する治療として用いられ、多くの患者に効果をもたらしています。また、心臓の機能を調整するためのペースメーカーや植込み型除細動器も生体電気医療の一環として考えられています。これらのデバイスは、心臓のリズムをモニターし、異常があれば自動的に電気的な刺激を与えることで、正常な心拍を維持する役割を果たしています。

さらに、電気刺激治療の一環として、筋肉への電気刺激を行う筋電図（EMG）や電気刺激リハビリテーションがあります。これは、筋肉の動きを促進したり回復させたりするためのもので、特に運動機能を失った患者のリハビリテーションに使用されることが多いです。これに加えて、電気的神経刺激装置を使用した疼痛管理も広く行われています。外科手術後や慢性的な痛みを抱える患者へのアプローチとして、日常的に実施されています。

生体電気医療の用途は非常に広範囲にわたります。内科的治療、リハビリテーション、疼痛管理、心臓病の治療など、患者の状態に応じて応用されています。また、より最近では、脳深部刺激療法や脳波を用いた神経療法など、脳に関連した治療法も開発が進んでいます。特に、パーキンソン病やうつ病などの治療に対して新たなアプローチとして注目されています。

生体電気医療には、関連する先進技術も数多く存在します。例えば、電気生理学的診断技術、神経画像技術、バイオセンサーなどがこれに含まれます。電気生理学的診断技術は、心拍数や脳波を測定･解析し、異常を特定するために使用されます。これにより、病状の診断がより迅速かつ正確になります。

また、バイオセンサーは、生体信号をリアルタイムでモニタリングすることができ、外部デバイスと連携することで、患者の健康状態を常時監視することを可能にします。これにより、急な健康危機に対して迅速な対応が可能となり、患者の安全が確保されます。

さらに、人工知能（AI）の活用も進んでおり、データ解析やパターン認識を通じて、より適切な治療法の提案や患者へのケアの最適化が期待されています。AIを用いた研究が進むことで、生体電気医療の分野はますます進化し、効果的な治療法が提供されるようになるでしょう。

生体電気医療は、患者の生活の質を向上させるために重要な役割を果たしており、今後の研究開発によってさらなる進展が期待されています。新たな治療法や技術の発展により、多くの人々がより良い医療を享受できる未来が実現することを願っています。この分野は急速に進化しており、医療従事者や研究者による継続的な努力が求められています。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

生体電気医療の世界市場：産業分析・成長予測（～2030）

グローバル市場調査会社